CClinicalTrials.gg
CompletedNCT01673958Updated Aug 28, 2012

Stair Descending vs. Stair Ascending Exercise

An interventional study of Exercise in Aging, Heart Failure and Sarcopenia, sponsored by European University Cyprus. Completed at 1 site in Cyprus. Open to male participants aged 60 Years to 70 Years. Per ClinicalTrials.gov, last updated 2012-08-28.

Sponsored by European University Cyprus · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
60 Years to 70 Years
Sex
Male
01

Study summary

The aim of the present project is to compare the acute and chronic effect of stair descending versus stair ascending exercise on muscle damage and performance in elderly males with chronic heart failure.

Read the detailed description

Study design:

Twelve elderly males with chronic heart failure, New York Heart Association class I-II, will participate in this study. Participants will be allocated into two equally-sized groups: a stair descending group (n = 6) and a stair ascending group (n = 6). At the beginning of the study, the volunteers will perform an acute bout of stair descending or stair ascending exercise on an automatic escalator (4 sets of 3 min each, speed will be set at 45 steps∙min-1). Step height will be 20.5 mm. Before and at day 2 post exercise, physiologic measurements will be performed and blood samples will be collected. Then, participants will carry out six weeks of stair descending or ascending training consisting of three exercise sessions per week (the first two weeks the speed will be set at 45 steps∙min-1, the next two weeks at 50 steps∙min-1 and the last two weeks at 55 steps∙min-1 for both groups). Afterward, they will repeat the acute stair descending or ascending protocol, as carried out at the beginning of the study, and the same physiologic measurements will be performed and blood samples will be collected.

Measurements:

Isometric (at 90 knee flexion), concentric and eccentric peak torque at 60o∙s-1of quadriceps femoris, pain-free range of motion, delayed onset muscle soreness and creatine kinase will be measured.

02

Conditions studied

  • Aging
  • Heart Failure
  • Sarcopenia

Keywords

  • Eccentric exercise
  • Aging
  • Heart failure
  • Muscle strength loss
  • Sarcopenia
03

In context

Sarcopenia

1,208 studies on the registry are indexed under Sarcopenia; 401 are open to participants now.

This study's enrollment of 12 is below the median of 60 across 773 interventional studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

European University Cyprus is the lead sponsor of 15 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 70 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • chronic heart failure (New York Heart Association class I-II)
  • subject provides written informed consent
  • personal physician of the participants provides written informed consent

Exclusion criteria

Exclusion Criteria:

  • smoker
  • consumed any nutritional supplement the last 3 months
  • performed intense eccentric exercise the last 6 months
  • non Caucasian
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Stair descending group

    Stair descending exercise. Participants will carry out six weeks of stair descending training consisting of three exercise sessions per week.

    Other: Exercise

  • Experimental
    Stair ascending group

    Stair ascending exercise. Participants will carry out six weeks of stair descending training consisting of three exercise sessions per week.

    Other: Exercise

Interventions

  • OtherExercise

    Comparison between stair descending and stair ascending training

06

What researchers measure

Primary outcomes

  1. Muscle strength (torque)

    An isokinetic dynamometer (Cybex, Ronkonkoma, NY) will be used for the measurement of isometric, eccentric and concentric knee extensor peak torque at 90° knee flexion. The average of the three best maximal voluntary contractions with their dominant leg will be recorded. In order to ensure that the subjects provide their maximal effort, the measurements will be repeated if the difference between the lower and the higher torque value exceeded 10%. There will be two minutes rest between isometric efforts.

    Time frame: Change from baseline in muscle strength at day 2 post exercise at the first and sixth week of training

Secondary outcomes

  1. Pain free range of motion (degrees)

    The assessment of pain-free ROM will be performed manually using the the isokinetic dynamometer. The investigator will move the calf at a very low angular velocity from 0 knee extension to the position where the subject will feel any discomfort.

    Time frame: Before and at day 2 post exercise at the first and sixth week of training

  2. Creatine kinase, CK (activity IU)

    CK activity will be measured as a general indicator of muscle damage.It will be measured in a Cobas Integra Plus 400 chemistry analyzer.

    Time frame: Before and at day 2 post exercise at the first and sixth week of training

  3. Delayed onset muscle soreness, DOMS (scale 1-10)

    Each participant will assess delayed onset muscle soreness (DOMS) during squat movement (90o knee flexion) and perceived soreness will be rated on a scale ranging from 1 (normal) to 10 (very sore).

    Time frame: Before and at day 2 post exercise at the first and sixth week of training

07

Study locations

1 site
  • European University Cyprus
    Nicosia, 1516, Cyprus
08

References and documents

Publications

  • Paschalis V, Nikolaidis MG, Theodorou AA, Panayiotou G, Fatouros IG, Koutedakis Y, Jamurtas AZ. A weekly bout of eccentric exercise is sufficient to induce health-promoting effects. Med Sci Sports Exerc. 2011 Jan;43(1):64-73. doi: 10.1249/MSS.0b013e3181e91d90. PubMed 20508540 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01673958
Lead sponsor
European University Cyprus
Collaborators
University of Thessaly, Aristotle University Of Thessaloniki
Responsible party
Dr. Anastasios Theodorou (Principal investigator, European University Cyprus) — Principal investigator
First posted
Aug 28, 2012
Start date
Feb 2012
Primary completion
Apr 2012
Completion
Apr 2012
Last update
Aug 28, 2012

Study contacts

George Panayiotou, PhD
study chair · Research Centre, European University Cyprus

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion